Abyrx,™ Inc. Receives FDA 510(k) Clearance for New Hemasorb Plus™ Resorbable Hemostatic Bone Putty

Abyrx,™ Inc. Receives FDA 510(k) Clearance for New Resorbable Hemostatic Bone Putty (Hemasorb Plus™) (via PR Newswire)

IRVINGTON, N.Y., Sept. 4, 2013 /PRNewswire/ — Abyrx, Inc., a privately-held therapeutic device company, today announced that the United States Food and Drug Administration has cleared its new resorbable hemostatic bone putty (Hemasorb Plus™) for…